MARKIE MEMINGER: Open Payments
NPI 1114280187 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 34 payments from 13 companies in 2025. Trend: 2023 $707 · 2024 $354 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $131 |
| Biogen, Inc. | 5 | $104 |
| Sumitomo Pharma America, Inc. | 1 | $84 |
| ABBVIE INC. | 2 | $62 |
| MILLICENT US INC | 4 | $62 |
| Exeltis, USA Inc. | 3 | $61 |
| Organon LLC | 4 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $40 |
| Mayne Pharma Commercial LLC | 2 | $38 |
Products named: ZURZUVAE, GEMTESA, ABRYSVO, LILETTA, SLYND, NEXPLANON, COMIRNATY, FEMLYV.
Industry payments across IL — which companies pay providers there.
